Literature DB >> 10651310

Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.

T Yoshizaki1, H Sato, S Murono, J S Pagano, M Furukawa.   

Abstract

Type IV collagenases, matrix metalloproteinase (MMP) 2 and MMP9 are implicated in tumor invasion and metastasis. In patients with nasopharyngeal carcinoma (NPC), poor prognosis due to development of local and distant metastasis has been reported to be predicted by antibody titers against the Z protein which is an AP-1 family transcription factor encoded by the EBV BZLF1 immediate-early gene. Here we report that in patients with NPC, expression of Z in tumor cells correlates with advanced cervical lymph node metastasis which may suggest that Z affects tumor invasion and metastasis. We therefore tested if Z would induce expression of type IV collagenases. Transfection of Z expression plasmid into the C33A epithelial cell line increased expression of MMP9, but MMP2 expression was unaltered. Mutational analysis of the Z protein revealed that, in addition to all three functional domains of Z (dimerization domain, DNA binding domain, and activation domain), the carboxyl terminal 17 amino acids which stabilize the Z protein were necessary for induction of MMP9 expression. Analysis of the MMP9 promoter demonstrated that only AP-1 site close to the transcriptional start-site was essential for transactivation by Z. Previously we reported that Epstein-Barr virus latent membrane protein 1 (LMP1) stimulates MMP9 expression (Yoshizaki et al. Proc. Natl. Acad. Sci. 1998; 95: 3621-6). Thus, Z together with LMP1 may contribute to invasion and metastasis of NPC by inducing expression of MMP9.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10651310     DOI: 10.1023/a:1006699003525

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  32 in total

1.  Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism.

Authors:  J W Sixbey; Q Y Yao
Journal:  Science       Date:  1992-03-20       Impact factor: 47.728

2.  Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study.

Authors:  F de-Vathaire; H Sancho-Garnier; H de-Thé; C Pieddeloup; G Schwaab; J H Ho; R Ellouz; C Micheau; M Cammoun; Y Cachin
Journal:  Int J Cancer       Date:  1988-08-15       Impact factor: 7.396

3.  Long-term follow-up of IgG and IgA antibodies against viral capsid antigens of Epstein-Barr virus in nasopharyngeal carcinoma.

Authors:  T C Lynn; S M Tu; A Kawamura
Journal:  J Laryngol Otol       Date:  1985-06       Impact factor: 1.469

4.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.

Authors:  T Yoshizaki; H Sato; Y Maruyama; S Murono; M Furukawa; C S Park; M Seiki
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

6.  Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.

Authors:  E J Bernhard; S B Gruber; R J Muschel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies.

Authors:  M I Gutierrez; K Bhatia; I Magrath
Journal:  Leuk Res       Date:  1993-03       Impact factor: 3.156

8.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

9.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

10.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

Authors:  S Zalani; E Holley-Guthrie; S Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

View more
  17 in total

1.  Expression of matrix metalloproteinase 9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection.

Authors:  Jian-Guo Tang; Xuan Li; Ping Chen
Journal:  J Zhejiang Univ Sci       Date:  2004-10

2.  Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol).

Authors:  Hratch Arbach; Viktor Viglasky; Florence Lefeu; Jean-Marc Guinebretière; Vanessa Ramirez; Nadège Bride; Nadia Boualaga; Thomas Bauchet; Jean-Philippe Peyrat; Marie-Christine Mathieu; Samia Mourah; Marie-Pierre Podgorniak; Jean-Marie Seignerin; Kenzo Takada; Irène Joab
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma.

Authors:  T Horikawa; T S Sheen; H Takeshita; H Sato; M Furukawa; T Yoshizaki
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph.

Authors:  Delphine Casabonne; Oscar Reina; Yolanda Benavente; Nikolaus Becker; Marc Maynadié; Lenka Foretová; Pierluigi Cocco; Anna González-Neira; Alexandra Nieters; Paolo Boffetta; Jaap M Middeldorp; Silvia de Sanjose
Journal:  Haematologica       Date:  2010-11-03       Impact factor: 9.941

5.  Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.

Authors:  Gregory K Hong; Pawan Kumar; Ling Wang; Blossom Damania; Margaret L Gulley; Henri-Jacques Delecluse; Peter J Polverini; Shannon C Kenney
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma.

Authors:  Jing Chen; Chun-Fang Hu; Jing-Hui Hou; Qiong Shao; Li-Xu Yan; Xiao-Feng Zhu; Yi-Xin Zeng; Jian-Yong Shao
Journal:  J Transl Med       Date:  2010-03-26       Impact factor: 5.531

7.  The cervical malignant cells display a down regulation of ER-α but retain the ER-β expression.

Authors:  Ricardo López-Romero; Efraín Garrido-Guerrero; Angélica Rangel-López; Leticia Manuel-Apolinar; Patricia Piña-Sánchez; Minerva Lazos-Ochoa; Alejandra Mantilla-Morales; Cindy Bandala; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

8.  Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.

Authors:  Mengmeng Zhao; Asuka Nanbo; David Becnel; Zhiqiang Qin; Gilbert F Morris; Li Li; Zhen Lin
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

9.  Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.

Authors:  Shuo Chen; Xi Chen; Yin-Ling Xiu; Kai-Xuan Sun; Yang Zhao
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

10.  Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.

Authors:  Yu-Yan Lan; Tzu-Hao Yeh; Wei-Hung Lin; Shih-Yi Wu; Hsiao-Ching Lai; Fang-Hsin Chang; Kenzo Takada; Yao Chang
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.